share_log

Viridian Chart Of The Week: Maybe It Really IS All About Earnings

Benzinga ·  Mar 7, 2023 02:20

Earnings season is upon us again, and most public cannabis companies will release results for the 4th quarter of 2022 in the next few weeks. Only two of the companies in the graph have reported to date. Green Thumb (OTC:GTBIF) beat consensus revenue estimates by 1% and EBITDA estimates by 1.2%, while MariMed (OTC:MRMD) beat revenue estimates by 2% but missed EBITDA by 33.8%.

  • In digesting the releases, investors will pay particular attention to EBITDA and cash levels—achieving positive cash flow and maintaining liquidity trump growth in this environment.

  • We will also be focusing on estimate revisions. We have been tracking consensus analyst...

Login or create a forever free account to read this news
Sign up/Log in
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment